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Abstract
Background:  Theca cells play an important role in controlling ovarian steroidogenesis by
providing aromatizable androgens for granulosa cell estrogen biosynthesis. Although it is well
established that the steroidogenic activity of theca cells is mainly regulated by LH, the intracellular
signal transduction mechanisms that regulate thecal proliferation and/or steroidogenesis remain
obscure. In this study, we examined whether and how LH controls the PI3K/Akt signaling pathway
and androgen production in bovine theca cells. We also explored whether this LH-induced PI3K/
Akt activation is modulated with other signaling pathways (i.e. PKA and MAPK).
Methods: Ovarian theca cells were isolated from bovine small antral follicles and were incubated
with LH for various durations. Phospho-Akt and total-Akt content in the cultured theca cells were
examined using Western blotting. Androstenedione levels in the spent media were determined
using EIA. Semi-quantitative RT-PCR analyses were conducted to analyze the mRNA levels of
CYP17A1 and StAR in the theca cells. To examine whether Akt activity is involved in theca cell
androgen production, the PI3K inhibitors wortmannin and LY294002 were also added to the cells.
Results: Akt is constitutively expressed, but is gradually phosphorylated in cultured bovine theca
cells through exposure to LH. LH significantly increased androstenedione production in bovine
theca cells, whereas addition of the wortmannin and LY294002 significantly decreased LH-induced
androstenedione production. LH significantly increased CYP17A1 mRNA level in theca cells,
whereas addition of LY294002 significantly decreased LH-induced CYP17A1 expression. Neither
LH nor PI3K inhibitors alter the mRNA levels of StAR in theca cells. Although H89 (a selective
inhibitor of PKA) does not affect LH-mediated changes in Akt, U0126 (a potent MEK inhibitor)
suppressed LH-induced Akt phosphorylation, CYP17A1 expression, and androgen production in
theca cells.
Conclusion: These results indicate that LH stimulates CYP17 mRNA expression and androgen
production in theca cells via activation of the PI3K/Akt pathway. The LH-induced Akt
phosphorylation and androgen production are modulated by the MAPK signaling in bovine theca
cells.
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Background
The principal function of ovarian theca cells is steroid hor-
mone production. Theca cells play an important role in
controlling ovarian steroidogenesis by providing aroma-
tizable androgens for granulosa cell estrogen biosynthesis
[1]. Androgens also function as local regulators of ovarian
folliculogenesis upon binding androgen receptors local-
ized to granulosa cells, stromal cells, and oocytes [2].
Androgen receptor null mice culminate in reduced fertility
and premature ovarian failure [3], indicating that andro-
gens are necessary for reproductive function and fertility.
Normal ovarian function requires accurate regulation of
steroidogenic activity of theca cells through extraovarian
and intraovarian mechanisms. Thecal steroidogenic
hyperactivity can cause ovarian dysfunction, such as poly-
cystic ovary syndrome (PCOS) [4].
It is well established that theca cell steroidogenesis is
under the primary control of luteinizing hormone (LH)
through the second-messenger cAMP-protein kinase A
(PKA) pathway [5,6]. Moreover, LH stimulates theca cells
to produce androgens and to maintain progesterone pro-
duction by the induction of genes involved in steroido-
genesis: cytochrome P450 side-chain cleavage enzyme
(CYP11A1), 3β-hydroxysteroid dehydrogenase, 17α-
hydroxylase/C17-20 lyase cytochrome P450 (CYP17A1),
and steroidogenic acute regulatory protein (StAR) [7-10].
Intracellular signaling mechanisms that regulate ovarian
follicular development and/or steroidogenesis remain
obscure [11]. Nevertheless, LH reportedly activates the
extracellular-signal-regulated kinases (ERK)/mitogen acti-
vated protein kinase (MAPK) pathway in ovarian granu-
losa and theca cells [12]. Although FSH and several
growth factors are known to activate the phosphatidyli-
nositol 3' kinase (PI3K)/Akt pathway in granulosa cells
[13-15], whether LH stimulates the PI3K/Akt cascade in
theca cells is not clear. Although LH augments androgen
production in theca cells, it remains unknown whether
this response is mediated via activation of the PI3K/Akt
pathway.
In this study, we examined whether and by what means
LH controls PI3K/Akt signaling and androgen production
using cultured bovine theca cells. We demonstrated that
LH stimulates CYP17A1 mRNA expression and androgen
production in theca cells via activation of the PI3K path-
way. Both the PI3K and the MAPK pathways coordinately
regulate androgen production in bovine theca cells.
Methods
Exprimental design
Experiment 1
To examine whether LH stimulates PI3K/Akt signaling in
theca cells, bovine theca cells from small antral follicles
were incubated with LH for various durations (0, 5 min,
20 min, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h, 24 h, and 48 h), and
phospho-Akt and total-Akt content were examined using
Western blotting.
Experiment 2
To examine whether Akt activity is involved in theca cell
androgen production, theca cells were pretreated for 30
min with the PI3K inhibitors, wortmannin (0.1 μM) and
LY294002 (25 μM). The cells were subsequently stimu-
lated with LH (100 ng/ml) for 24 h. Androstenedione lev-
els in the spent media were determined using EIA.
Experiment 3
Along with examining androstenedione production,
semi-quantitative RT-PCR analyses were conducted to
analyze the mRNA levels of CYP17A1 and StAR in the cul-
tured theca cells at 12 h of incubation.
Experiment 4
Whether PKA or MAPK pathway influence LH-induced
Akt phosphorylation in theca cells was explored. Theca
cells were pretreated with H89 (i.e. a selective inhibitor of
PKA [16]), and U0126 (i.e. a potent MEK inhibitor) for 30
min. The cells were subsequently stimulated with LH (100
ng/ml) for 24 h. Phospho-Akt and total-Akt content in the
cultured theca cells were examined using Western blot at
24 h of the culture. CYP17A1 mRNA levels in the theca
cells and androstenedione levels in the spent media were
also determined.
Antibodies
Rabbit polyclonal anti-phospho-Akt (i.e. active Akt) anti-
bodies and anti-total-Akt antibodies were purchased from
Cell Signaling Technologies (Beverly, MA). Goat anti-rab-
bit IgG coupled to horseradish peroxidase was purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Reagents
Human LH was provided by the National Institutes of
Health and Dr. A. F. Parlow (National Hormone and Pep-
tide Program, Torrance, CA). LY294002 (a PI3K inhibitor)
was from Sigma Chemical Co. (St. Louis, MO), and wort-
mannin (a PI3K inhibitor), H89 (a selective inhibitor of
PKA), and U0126 (a potent MEK inhibitor) were pur-
chased from Calbiochem Novabiochem Corp. (San
Diego, CA).
Theca cell culture
Bovine ovaries were collected less than 15 min after
slaughter at a local abattoir. The ovaries were placed in an
ice-cold buffered salt solution and transferred to the labo-
ratory less than 90 min after collection. The estrous cycle
stage was determined morphologically, as described pre-
viously by Ireland et al [17]; only those ovaries with a
regressing corpus luteum were used for this study. Theca
cells were isolated from the ovaries under sterile condi-Journal of Ovarian Research 2009, 2:17 http://www.ovarianresearch.com/content/2/1/17
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tions, as described previously [18]. Briefly, small antral
follicles (2-4 mm diameter) with clear surfaces were cut
into halves and theca interna removed in situ using fine
forceps. Granulosa cells, together with part of the theca
cell layer, were removed by scraping with a scalpel under
a stereomicroscope. The resultant thin thecal layer was
minced and subsequently treated with a Hanks'-HEPES
buffer containing collagenase (2150 U/ml, type 1; Sigma)
and DNase (100 U/ml; Sigma), 0.4% (vol/vol) BSA, and
0.2% (wt/vol) glucose (pH 7.4). Cell dissociation was
allowed to continue for 30-60 min at 37°C with continu-
ous stirring at 80 rpm and 0.25% (wt/vol) pancreatin
(Sigma) in a Hanks'-HEPES buffer for 7 min. Dispersed
cells were washed three times. Cell viability, as deter-
mined using the trypan blue-dye exclusion test, was 90-
93%. Purity of the theca cell preparation used in this study
was substantiated by the secretion of estradiol; prepared
theca cells did not produce estradiol in the presence or
absence of forskolin, whereas granulosa cells obtained
from the same follicle secret significant (data not shown).
Isolated theca cells were plated onto serum-coated dishes
with serum-free medium for 36 h. Then they were stimu-
lated with LH (100 ng/ml) for various durations (0, 5
min, 20 min, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h, 24 h, and 48 h).
Preliminary data indicated that 100 ng/ml of LH is the
minimal effective concentration for inducing a significant
increase in androgen production and CYP17A1 expres-
sion in our culture system.
Western blot analysis
Western blot analysis was conducted as described previ-
ously [12]. Briefly, primary cultures at the end of incuba-
tion with the appropriate stimulant or no stimulation as
indicated in each experiment were rinsed with ice-cold
PBS and once with buffer A [50 mM β-glycerophosphate
(pH 7.3), 1.5 mM EGTA, 1 mM EDTA, 1 mM dithiothrei-
tol, and 0.1 mM sodium vanadate] and were subsequently
harvested in buffer A plus proteinase inhibitors. Cell
lysates were centrifuged at 20,000 × g for 20 min. The
supernatant was assayed for protein content and subjected
to Western blot analysis to detect anti-phospho-Akt and
anti-total-Akt. Samples containing equal amounts of pro-
tein (40 μg) were separated by 10% acrylamide SDS-
PAGE. The relevant proteins were detected on blots using
their specific antibodies.
Determination of androstenedione levels
Androstenedione levels were determined using EIA at the
end of the stimulation. Protein was quantified using the
Bradford method.
RNA extraction and RT-PCR
Total RNA was isolated using TRIzol (Invitrogen Corp.,
Carlsbad, CA) according to the manufacturer's instruc-
tions. The RNA pellets were ethanol precipitated, washed,
and resuspended in sterile ribonuclease-free water. Qual-
ity of the RNA was assessed by fractionating it on 1% aga-
rose gel and observing the presence of the typical 28S and
18S rRNA under UV light. RT-PCR analyses for bovine
CYP17A1, StAR, and 36B4 (an acidic ribosomal phospho-
protein as an internal control) were performed on total
RNAs from cultured theca cells using specific primers.
Primers used for bovine CYP17A1 were 5'-TCAGA-
GAAGTGCTCCGAATCC-3' and 5'-TGCCACTCCTTCT-
CACTGTGA-3'; those for bovine StAR were 5'-
TCGCGGCTCTCTCCTAGGT-3' and 5'-CTGCCG-
GCTCTCCTTCTTC-3', and those for bovine 36B4 were 5'-
GGCGACCTGGAAGTCCAACT-3' and 5'-GGATCTGCT-
GCATCTGCTTG-3', respectively. In each case, RNAs were
reverse transcribed in a final volume of 40 μl solution con-
taining 1× first-strand buffer [3 mM MgCl2, 75 mM KCl,
50 mM Tris-HCl (pH 8.3)], 500 μM each deoxynucleotide
triphosphate, 10 mM dithiothreitol, 200 U SuperScript III
RNase H-free reverse transcriptase (Invitrogen Corp.), 200
ng random hexamers, and 2 μg total RNA. The target
cDNAs were amplified for 30 cycles (CYP17A1 and StAR)
and 25 cycles (36B4, internal control), respectively, in a
thermal cycler (94 C for 20 s, 60 C for 30 s, and 72 C for
60 s) using deoxynucleotide triphosphate (0.2 mM) and
1.5 U of TaKaRa Ex Taq (Takara Shuzo Co. Ltd., Kyoto,
Japan). Aliquots of PCR products were electrophoresed on
1.5% agarose gels and stained with ethidium bromide.
The relative integrated density of each band was scanned
and digitized using FluorChem (Alpha Innotech Corpora-
tion, San Leandro, CA); the ratios of densitometric read-
ings of the amplified target cDNA and internal control,
36B4, DNA were analyzed.
Statistical analysis
All experiments were repeated at least three times using
theca cells obtained from separate groups of bovines. Data
were subjected to ANOVA. Group means were contrasted
using Tukey's post hoc multiple comparison test. P < 0.05
was considered significant. All values are expressed as
mean ± SEM.
Results
Experiment 1
LH increases phospho-Akt content in bovine theca cells
Total-Akt was present in theca cells at 0 h and remained
constant during culture with LH. During the 5 min to 8 h
of culture, Akt was not phosphorylated by LH. However,
the amount of phospho-Akt began to increase at 12 h and
reached its highest level (five-fold higher than baseline) at
24 h after addition of LH (Fig. 1).
Experiment 2
Effects of the PI3K inhibitors on LH-induced androgen production in 
theca cells
Results show that LH significantly increased androstene-
dione production in bovine theca cells. Addition of the
PI3K inhibitors wortmannin and LY294002 significantlyJournal of Ovarian Research 2009, 2:17 http://www.ovarianresearch.com/content/2/1/17
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decreased LH-induced androstenedione production in
theca cells (Fig. 2).
Experiment 3
Effects of the PI3K inhibitors on CYP17 and StAR mRNA expressions 
in theca cells
Results show that LH significantly increased CYP17A1
mRNA level in the theca cells. Addition of LY294002, but
not wortmannin, significantly decreased LH-induced
CYP17A1 mRNA expression (Fig. 3). Neither LH nor the
PI3K inhibitors alter the mRNA levels of StAR in the theca
cells.
Experiment 4
Effect of PKA inhibitor and MEK inhibitor on LH-induced Akt 
phosphorylation
In fact, H89 (i.e. a selective inhibitor of PKA) did not
affect LH-mediated changes in Akt. On the other hand,
U0126 (i.e. a potent MEK inhibitor) inhibited LH-
induced Akt phosphorylation in the theca cells (Fig. 4).
Although LH stimulated CYP17A1 mRNA expression and
androstenedione production in the theca cells, the MAPK
cascade inhibitor (U0126) completely blocked these
responses (Fig. 5).
Discussion
In this study, we demonstrated that: 1) Akt is constitu-
tively expressed, but is gradually phosphorylated in cul-
tured bovine theca cells through exposure to LH; 2) LH
stimulated androstenedione production in theca cells,
although addition of the PI3K inhibitors (i.e. wortmannin
and LY294002) attenuated LH-induced androstenedione
production; 3) LH increased CYP17A1 mRNA level in
theca cells, whereas addition of LY294002 suppressed LH-
induced CYP17A1 expression in theca cells; 4) although
H89 (i.e. a selective inhibitor of PKA) did not affect LH-
mediated changes in Akt, U0126 (i.e. a potent MEK inhib-
itor) inhibited the LH-induced Akt phosphorylation,
CYP17A1 expression, and androgen production in theca
cells. These results suggest that LH stimulates CYP17A1
mRNA expression and androgen production in theca cells
via activation of the PI3K/Akt pathway, and that the
MAPK, not PKA, is involved in LH stimulation of the
PI3K/Akt cascade in bovine theca cells.
Time-course effect of LH on Akt phosphorylation in bovine  theca cells Figure 1
Time-course effect of LH on Akt phosphorylation in 
bovine theca cells. Theca cells were plated onto serum-
coated dishes with serum-free medium for 36 h and then 
stimulated with LH (100 ng/ml) for the stated times. 
Cytosolic extracts (20 μg) were subjected to immunoblotting 
with anti-phosphorylated-Akt antibody and anti-total-Akt 
antibody. Representative images (Top) and densitometric 
data of phospho-Akt contents (Bottom), expressed as ratio of 
phospho-Akt to total-Akt, are shown. * denotes means that 
are significantly different from 0 h (P < 0.01). ** denotes 
means that are significantly different from 0 h (P < 0.001).
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Effects of PI3K inhibitors on androstenedione production in  bovine theca cells Figure 2
Effects of PI3K inhibitors on androstenedione pro-
duction in bovine theca cells. Bovine theca cells were 
stimulated with LH (100 ng/ml), wortmannin (W, 0.1 μM), 
LY294002 (LY, 25 μM), or their combination for 24 h in 
serum-coated dishes with serum-free medium. Control cells 
(CTL) were cultured in the absence of added treatments. 
Culture media were assayed for androstenedione by EIA. 
Values are means ± SEM for four experiments. Different let-
ters denote a significant difference of means (P < 0.05).
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PI3K converts phosphatidylinositol-4,5-biphosphate to
phosphatidylinositol-3,4,5-triphosphate, leading to acti-
vation of downstream kinases including Akt, which in
turn phosphorylates Bad, forkhead in rhabdomyosar-
coma (FKHR), Fas-associated death domain-like IL-1β-
converting enzyme-like inhibitory protein (FLIP), and X-
linked inhibitor of apoptosis protein (XIAP) [19]. The
PI3K/Akt activation drives cell through many biological
functions, including gene expression, cell cycle, survival,
glucidic metabolism, endocytosis and vesicular traffick-
ing, cell transformation, and oncogenesis [20]. In ovary,
FSH and several growth factors are known to activate the
PI3K/Akt pathway and prevent apoptosis in granulosa
cells and cultured follicles [13-15]. Although LH has been
reported to activate the cAMP/PKA pathway [4] and the
ERK/MAPK pathway [12] in theca cells, whether LH stim-
ulates the PI3K/Akt cascade in theca cells remains unclear.
Results of this study show for the first time that 1) LH
stimulates Akt phosphorylation in cultured bovine theca
cells, and that 2) activation of PI3K/Akt is involved in
CYP17A1 mRNA expression and androgen production in
Effects of PI3K inhibitors on mRNA expression of CYP17A1  and StAR in bovine theca cells Figure 3
Effects of PI3K inhibitors on mRNA expression of 
CYP17A1 and StAR in bovine theca cells. Theca cells 
were incubated with LH in the presence or absence of wort-
mannin (0.1 μM) or LY294002 (25 μM) in serum-coated 
dishes with serum free medium for 12 h. Control cells (CTL) 
were cultured in the absence of added treatments. Then RT-
PCR was conducted using CYP17A1, StAR, and 36B4 (inter-
nal control) primers using total RNA isolated from the cells. 
The products were fractionated on 1% agarose gel and 
stained with ethidium bromide. The mRNA levels of 
CYP17A1 and StAR were expressed as ratio to 36B4 values. 
Data are the mean ± SEM (n = 5). Different letters represent 
statistically significant differences of means (P < 0.05).
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Effects of PKA inhibitor, MEK inhibitor and PI3K inhibitors  on Akt phosphorylation in bovine theca cells Figure 4
Effects of PKA inhibitor, MEK inhibitor and PI3K 
inhibitors on Akt phosphorylation in bovine theca 
cells. Subconfluent cultures were pretreated with PKA inhib-
itor (H89, 3 μM), MEK inhibitor (U0126, 10 μM), or PI3K 
inhibitors (wortmannin, 0.1 μM; LY294002, 25 μM) for 30 
min. Then they were stimulated with LH (100 ng/ml) for 24 
h. Control cells (CTL) were cultured in the absence of added 
treatments. Cell lysates (20 μg) were subjected to SDS-
PAGE and Western blot using anti-phosphorylated-Akt anti-
body (Phospho-Akt) or anti-total-Akt antibody (Total-Akt). 
Representative images (Top) and densitometric data of phos-
pho-Akt contents (Bottom), expressed as a ratio of phospho-
Akt to total-Akt, are shown. Values show the mean ± SEM 
for three experiments. Each experiment was reproduced at 
least three times. Different letters denote significant differ-
ences of means (P < 0.05).
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theca cells. Reportedly, LH induced Akt phosphorylation
in whole rat ovary [21], and the PI3K inhibitor,
LY294002, suppressed androstenedione production by
theca cells in rat [22] and cattle [11]. It is possible that LH-
stimulated Akt phosphorylation in theca cells is responsi-
ble for these observations reported earlier.
Both wortmannin and LY294002 are inhibitors of the
lipid-modifying enzymes known as PI3K, and many
researchers perform a parallel study by using both inhibi-
tors to probe the roles of PI3K in biological processes.
However, depending on the concentration examined,
these inhibitors could be non-specific and cytotoxic and
could complicate the interpretation of their findings. In
our system, the 0.1 μM of wortmannin and 25 μM of
LY294002 are the minimal effective concentrations for
blocking the LH-induced androstenedione production in
theca cells. Nevertheless, only LY294002 suppressed LH-
induced CYP17A1 mRNA expression, whereas wortman-
nin did not affect this response. While the reason for this
apparent discrepancy is not clear, it is worth noting that
wortmannin has been reported to be unstable in aqueous
solution and less specific than LY294002 [23,24]. Higher
concentration (> 0.1 μM) of wortmannin induced theca
cell detachment and apoptosis in our serum-free culture
system.
Numerous reports have described that an activation of the
intracellular signaling (i.e. cAMP/PKA, ERK/MAPK, and
PI3K/Akt) is a rapid reaction in most cells. However, in
this study, it took 12 h for LH-induced increase in phos-
pho-Akt content in theca cells. It is of interest whether
PKA pathway, which is considered to be a major mediator
of the LH-generated signaling, and/or the MAPK pathway
influence LH-induced Akt phosphorylation or not. Exper-
iment 4 was performed to verify this point.
As described earlier, H89, a potent and selective inhibitor
of PKA, did not affect LH-mediated changes in phospho-
Akt, indicating that a pathway distinct from that of PKA is
involved in LH-induced Akt phosphorylation in theca
cells. Until recently, the effects of cAMP were generally
thought to be mediated by activation of cAMP-dependent
PKA, a major cAMP target, followed by phosphorylation
of many intracellular targets, such as cAMP responsive ele-
ment binding protein (CREB) [25], resulting in changes in
ovarian gene expression such as CYP17A1. Nevertheless,
some effects of cAMP appear to be inexplicable by activa-
tion of PKA. For instance, TSH and cAMP regulate prolif-
eration of thyroid cells by mechanisms independent of
PKA [26-29]. Actually, cAMP binds specific guanine nucle-
otide exchange factors: cAMP-GEFs (also called exchange
protein activated by cAMP, Epac) [30,31]. Gonzalez-
Robayna et al. reported that cAMP-GEFs are expressed in
rat granulosa cells and that the cAMP-GEFs play a role in
FSH-induced activation of the PI3K/Akt pathway in gran-
ulosa cells by PKA-independent manner [32]. Whether
theca cells also express these regulatory components and
whether the (PKA-independent) cAMP-GEFs mechanism
Effects of MEK inhibitor on CYP17A1 mRNA expression and  androstenedione production in bovine theca cells Figure 5
Effects of MEK inhibitor on CYP17A1 mRNA expres-
sion and androstenedione production in bovine theca 
cells. Subconfluent cultures were pretreated with MEK 
inhibitor (U0126, 10 μM) for 30 min. Then they were stimu-
lated with LH (100 ng/ml) for 12-24 h. Control cells (CTL) 
were cultured in the absence of added treatments. RT-PCR 
was conducted using CYP17A1 and 36B4 (internal control) 
primers using total RNA isolated from the cells. The mRNA 
level of CYP17A1 were expressed as ratio to 36B4 values 
(Top). Culture media were also assayed for androstenedione 
by EIA (Bottom). Data are the mean ± SEM (n = 4). Each 
experiment was reproduced at least three times. Different let-
ters represent statistically significant differences of means (P < 
0.05).
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is involved in LH-induced Akt phosphorylation in theca
cells remains to be elucidated.
In contrast to PKA inhibitor, the MEK inhibitor (U0126)
blocked LH-mediated Akt phosphorylation and androgen
production in theca cells. Reportedly, the MAPK inhibitor
also inhibits FSH-mediated Akt phosphorylation in rat
granulosa cells [32]. While the precise mechanism for the
activation of PI3K pathway by LH in theca cells is not
known, it is possible that the LH-induced phospho-Akt
up-regulation may involve MAPK-mediated down-regula-
tion of phosphatase and tensin homologue (PTEN; a
tumor suppressor which negatively regulates Akt phos-
phorylation). In this context, it has been shown that PI3K
is required for estradiol-stimulated hepatic cell growth
and that the MAPK pathway reduces the level of PTEN,
allowing estradiol-induced phosphorylation of Akt [20].
Whether this indeed is the case in the theca cells awaits
further investigation.
As a mechanism explaining why phospho-Akt content in
theca cells was increased only after 12 h of incubation
with LH, we are also interested in autocrine effects of insu-
lin-like growth factor-II (IGF-II) and nerve growth factor
(NGF) on theca cells. Reportedly, theca cells express IGF-
II and NGF in cattle, and each of IGF-II and NGF stimulate
androgen production [33,34]. Whether LH induces gene/
protein expression of these growth factors, and whether it
modulates the LH-mediated Akt phosphorylation in theca
cells, are subjects that are currently under investigation in
our laboratory.
Conclusion
Taking this evidence together, we conclude that LH stim-
ulates CYP17A1 mRNA expression and androgen produc-
tion in theca cells via activation of the PI3K/Akt pathway.
LH acts in theca cells by PKA-independent mechanisms as
well as PKA-dependent mechanisms, each of which con-
trols androgen production. Both the PI3K and the MAPK
pathways coordinately regulate androgen production in
bovine theca cells. Clarification of the LH-mediated intra-
cellular signaling events is essential for better understand-
ing of not only ovarian physiology, but also of the
pathophysiology of PCOS.
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